CG
Clarus Group’s Merck MRK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Sell |
4,624
-559
| -11% | -$44.3K | 0.13% | 68 |
|
|
2025
Q1 | $465K | Buy |
5,183
+387
| +8% | +$34.7K | 0.18% | 53 |
|
|
2024
Q4 | $477K | Buy |
4,796
+9
| +0.2% | +$895 | 0.17% | 55 |
|
|
2024
Q3 | $544K | Sell |
4,787
-1,836
| -28% | -$208K | 0.23% | 48 |
|
|
2024
Q2 | $820K | Buy |
6,623
+208
| +3% | +$25.7K | 0.36% | 35 |
|
|
2024
Q1 | $846K | Sell |
6,415
-356
| -5% | -$47K | 0.59% | 32 |
|
|
2023
Q4 | $738K | Sell |
6,771
-1,125
| -14% | -$123K | 0.56% | 35 |
|
|
2023
Q3 | $813K | Sell |
7,896
-968
| -11% | -$99.7K | 0.59% | 31 |
|
|
2023
Q2 | $1.02M | Buy |
8,864
+3,480
| +65% | +$402K | 0.75% | 22 |
|
|
2023
Q1 | $573K | Buy |
5,384
+12
| +0.2% | +$1.28K | 0.54% | 30 |
|
|
2022
Q4 | $596K | Buy |
5,372
+16
| +0.3% | +$1.78K | 0.52% | 31 |
|
|
2022
Q3 | $461K | Buy |
5,356
+14
| +0.3% | +$1.21K | 0.42% | 36 |
|
|
2022
Q2 | $487K | Buy |
5,342
+16
| +0.3% | +$1.46K | 0.41% | 41 |
|
|
2022
Q1 | $437K | Buy |
5,326
+78
| +1% | +$6.4K | 0.3% | 53 |
|
|
2021
Q4 | $393K | Buy |
5,248
+15
| +0.3% | +$1.12K | 0.26% | 53 |
|
|
2021
Q3 | $393K | Hold |
5,233
| – | – | 0.27% | 53 |
|
|
2021
Q2 | $408K | Sell |
5,233
-1,119
| -18% | -$87.2K | 0.31% | 54 |
|
|
2021
Q1 | $484K | Buy |
6,352
+17
| +0.3% | +$1.3K | 0.4% | 43 |
|
|
2020
Q4 | $475K | Buy |
+6,335
| New | +$475K | 0.41% | 42 |
|